ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01873339
Recruitment Status : Completed
First Posted : June 10, 2013
Last Update Posted : May 15, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 12, 2013
  Actual Study Completion Date : September 12, 2013